State-of-the-art consensus on non-transvenous implantable cardioverter-defibrillator therapy

被引：6

作者：

Schukro, Christoph ^{[1
]}

Santer, David ^{[2
]}

Prenner, Gunther ^{[3
]}

Stuehlinger, Markus ^{[4
]}

Martinek, Martin ^{[5
]}

Teubl, Alexander ^{[6
]}

Moertl, Deddo ^{[7
]}

Schwarz, Stefan ^{[8
]}

Nuernberg, Michael ^{[9
]}

Fiedler, Lukas ^{[6
]}

Hatala, Robert ^{[10
,11
]}

Khazen, Cesar ^{[12
]}

机构：

[1] Med Univ Vienna, Dept Internal Med 2, Div Cardiol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria

[2] Univ Hosp Basel, Dept Cardiac Surg, Basel, Switzerland

[3] Med Univ Graz, Dept Internal Med, Div Cardiol, Graz, Austria

[4] Med Univ Innsbruck, Dept Internal Med 3, Innsbruck, Austria

[5] Ordensklinikum Linz Elisabethinen Hosp, Dept Internal Med 1, Linz, Austria

[6] Wiener Neustadt State Hosp, Dept Internal Med 3, Wiener Neustadt, Austria

[7] Univ Hosp St Polten, Dept Internal Med 3, St Polten, Austria

[8] Kepler Univ Hosp Linz, Dept Internal Med 1, Linz, Austria

[9] Wilhelminen Hosp Vienna, Dept Internal Med 3, Vienna, Austria

[10] Natl Inst Cardiovasc Dis, Dept Arrhythmias & Cardiac Pacing, Bratislava, Slovakia

[11] Slovak Med Univ, Bratislava, Slovakia

[12] Med Univ Vienna, Dept Surg, Div Cardiac Surg, Vienna, Austria

来源：

CLINICAL CARDIOLOGY | 2020年 / 43卷 / 10期

关键词：

consensus document; non-transvenous implantable cardioverter defibrillator; recommendations; subcutaneous implantable cardioverter defibrillator; RANDOMIZED CONTROLLED-TRIAL; REDUCED EJECTION FRACTION; VENTRICULAR-FIBRILLATION; SHOCK EFFICACY; RISK-FACTORS; ICD; SAFETY; ELIGIBILITY; PERFORMANCE; PREDICTORS;

D O I：

10.1002/clc.23432

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Within the last decade, implantable cardioverter-defibrillator (ICD) systems with non-transvenous leads were developed in order to minimize complications related to the cardiovascular position of transvenous ICD leads. This national expert consensus gives an overview of potential indications for the implantation of non-transvenous ICD systems, and provides specific recommendations for implantation, follow-up, and complication management in patients with subcutaneous ICD. Regarding particular issues like the necessity for shock efficacy testing, or the clinical outcome as compared to transvenous ICD, randomized data are expected in the near future.

引用

页码：1084 / 1092

页数：9

共 50 条

[41] AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR
LATTUCA, J
VELTRI, EP
AMERICAN HEART JOURNAL, 1989, 118 (06) : 1359 - 1359
[42] Indications for implantable Cardioverter-Defibrillator
Tebbenjohanns, J
Niehaus, M
Korte, T
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2002, 127 (41) : 2120 - 2124
[43] AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR
EPSTEIN, AE
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1991, 102 (01): : 160 - 161
[44] The implantable cardioverter-defibrillator: An update
Miller, Jared D.
Yousuf, Omair
Berger, Ronald D.
TRENDS IN CARDIOVASCULAR MEDICINE, 2015, 25 (07) : 606 - 611
[45] Implantable cardioverter-defibrillator utilization
Camm, John
EUROPACE, 2011, 13 (03): : 448 - 448
[46] Erosion of an Implantable Cardioverter-Defibrillator
Elmouchi, Darryl
Woelfel, Alan
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (24) : E47 - E47
[47] Twiddling with an implantable cardioverter-defibrillator
McCann, Conor J.
Beelen, Roel
Geelen, Peter
ACTA CARDIOLOGICA, 2009, 64 (05) : 695 - 695
[48] Implantable cardioverter-defibrillator therapy in congenital heart disease
McLeod, Christopher J.
Kapa, Suraj
Asirvatham, Samuel J.
EXPERT REVIEW OF MEDICAL DEVICES, 2010, 7 (01) : 1 - 3
[49] Implantable cardioverter-defibrillator therapy after myocardial infarction
Steinbeck, G
Andresen, D
Senges, J
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (10): : 1039 - 1040
[50] Gender Bias Trends in Implantable Cardioverter-Defibrillator Therapy
Sahni S.
Fonarow G.C.
Current Cardiovascular Risk Reports, 2014, 8 (3) : 1 - 6

← 1 2 3 4 5 →